Association of cytotoxic T-lymphocyte associated antigen 4 gene polymorphism with type 1 diabetes mellitus: A meta-analysis

Gene

Volumn 508, Issue 2, 2012, Pages 165-187

  Tang, Song tao ^a   Tang, Hai qin ^a   Zhang, Qiu ^a   Wang, Chang jiang ^a   Wang, You min ^a   Peng, Wen jia ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Costimulatory molecule cytotoxic T lymphocyte associated antigen 4; Diabetes; Meta analysis; Polymorphism

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ARTICLE; ASIAN; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CAUCASIAN; DIABETES MELLITUS; DISEASE PREDISPOSITION; ETHNICITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HISPANIC; HUMAN; HUMAN GENOME; INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL ANALYSIS;

CTLA-4 ANTIGEN; DIABETES MELLITUS, TYPE 1; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC;

EID: 84865787200     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.07.044     Document Type: Article

References (82)

1. Abe T., et al. CTLA4 gene polymorphism correlates with the mode of onset and presence of ICA512 Ab in Japanese type 1 diabetes. Diabetes Res. Clin. Pract. 1999, 46:169-175.
2. Awata T., et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 1998, 47:128-129.
3. Balic I., Angel B., Codner E., Carrasco E., Perez-Bravo F. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children. Hum. Immunol. 2009, 70:116-120.
4. Baniasadi V., Narain N., Goswami R., Das S.N. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians. Tissue Antigens 2006, 67:383-389.
5. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
6. Benmansour J., et al. Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians. Clin. Vaccine Immunol. 2010, 17:1473-1477.
7. Bouqbis L., et al. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population. Genes Immun. 2003, 4:132-137.
8. Caputo M., et al. Cytotoxic T lymphocyte antigen 4 heterozygous codon 49 A/G dimorphism is associated to latent autoimmune diabetes in adults (LADA). Autoimmunity 2005, 38:277-281.
9. Caputo M., Cerrone G.E., Mazza C., Cédola N., Targovnik H.M., Gustavo D.F. No evidence of association of CTLA-4-318 C/T, 159 C/T, 3' STR and SUMO4 163 AG polymorphism with autoimmune diabetes. Immunol. Invest. 2007, 36:259-270.
10. Chelala C., et al. PTPN22 R620W functional variant in type 1 diabetes and autoimmunity related traits. Diabetes 2007, 56:522-526.
11. Cinek O., et al. The CTLA4 +49 A/G dimorphism is not associated with type 1 diabetes in Czech children. Eur. J. Immunogenet. 2002, 29:219-222.
12. Colucci F., Bergman M.L., Penha-Goncalves C., Cilio C.M., Holmberg D. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:8670-8674.
13. Cosentino A., Gambelunghe G., Tortoioli C., Falorni A. CTLA-4 gene polymorphism contributes to the genetic risk for latent autoimmune diabetes in adults. Ann. N. Y. Acad. Sci. 2002, 958:337-340.
14. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-188.
15. Ding H.G., Liu Y.M. The correlation of cytotoxic T lymphocyte-associated antigen 4 gene polymorphism with latent autoimmune diabetes. China Trop. Med. 2010, 10:396-397.
16. Djilali-Saiah I., et al. No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM. Diabetes 1998, 47:125-127.
17. Donner H., et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 1997, 82:143-146.
18. Douroudis K., et al. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum. Immunol. 2009, 70:536-539.
19. Douroudis K., Prans E., Kisand K., Nemvalts V., Uibo R. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms are associated with latent autoimmune diabetes in adults. Clin. Chim. Acta 2009, 403:226-228.
20. Douroudis K., Prans E., Uibo R. CTLA-4 promoter polymorphisms are associated with latent autoimmune diabetes in adults. Hum. Immunol. 2009, 70:921-924.
21. Easterbrook P.J., Berlin J.A., Gopalan R., Matthews D.R. Publication bias in clinical research. Lancet 1991, 337:867-872.
22. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
23. Ei Wafai R.J., Chmaisse H.N., Makki R.F., Fakhoury H. Association of HLA class II alleles and CTLA-4 polymorphism with type 1 diabetes. Saudi J. Kidney Dis. Transpl. 2011, 22:273-281.
24. Fajardy I., Vambergue A., Stuckens C., Weill J., Danze P.M., Fontaine P. CTLA-4 49 A/G dimorphism and type 1 diabetes susceptibility: a French case-control study and segregation analysis. Evidence of a maternal effect. Eur. J. Immunogenet. 2002, 29:251-257.
25. Ferreira A.C., Gomes K.B., Sampaio I.B., Oliveira V.C., Pardini V.C., Godard A.L. Type 1 diabetes susceptibility determined by HLA alleles and CTLA-4 and insulin genes polymorphisms in Brazilians. Arq. Bras Endocrinol. Metabol. 2009, 53:368-373.
26. Haller K., Kisand K., Nemvalts V., Laine A.P., Ilonen J., Uibo R. Type 1 diabetes is insulin -2221 MspI and CTLA-4 +49 A/G polymorphism dependent. Eur. J. Clin. Invest. 2004, 34:543-548.
27. Haller K., et al. Insulin gene VNTR, CTLA-4 +49A/G and HLA-DQB1 alleles distinguish latent autoimmune diabetes in adults from type 1 diabetes and from type 2 diabetes group. Tissue Antigens 2007, 69:121-127.
28. Harbo H.F., Celius E.G., Vartdal F., Spurkland A. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 1999, 53:106-110.
29. Hauache O.M., Reis A.F., Oliveira C.S., Vieira J.G., Sjoroos M., Ilonen J. Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes. Dis. Markers 2005, 21:139-145.
30. Hayashi H., et al. Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus. Clin. Endocrinol. (Oxf.) 1999, 51:793-799.
31. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 2002, 21:1539-1558.
32. Howson J.M., Dunger D.B., Nutland S., Stevens H., Wicker L.S., Todd J.A. A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene. Diabetologia 2007, 50:741-746.
33. Huang W., et al. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J. Clin. Endocrinol. Metab. 1996, 81:2559-2563.
34. Ide A., et al. Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. J. Autoimmun. 2004, 22:73-78.
35. Ihara K., et al. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population. Immunogenetics 2001, 53:447-454.
36. Ikegami H., et al. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J. Clin. Endocrinol. Metab. 2006, 91:1087-1092.
37. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003, 361:567-571.
38. Jin P., et al. Association of CTLA-4 +49A/G and CT60 gene polymorphism with type 1 diabetes and thyroid autoimmunity. Zhonghua Yi Xue Za Zhi 2009, 89:1246-1249.
39. Jin P., et al. High titre of antiglutamic acid decarboxylase autoantibody is a strong predictor of the development of thyroid autoimmunity in patients with type 1 diabetes and latent autoimmune diabetes in adults. Clin. Endocrinol. (Oxf.) 2011, 74:587-592.
40. Jung M.H., Yu J., Shin C.H., Suh B.K., Yang S.W., Lee B.C. Association of cytotoxic T lymphocyte antigen-4 gene polymorphisms and HLA class II alleles with the development of type 1 diabetes in Korean children and adolescents. J. Korean Med. Sci. 2009, 24:1004-1009.
41. Kamoun Abid H., et al. Association between type 1 diabetes and polymorphism of the CTLA-4 gene in a Tunisian population. Pathol. Biol. (Paris) 2001, 49:794-798.
42. Kavvoura F.K., Ioannidis J.P. CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus: a HuGE review and meta-analysis. Am. J. Epidemiol. 2005, 162:3-16.
43. Kawasaki E., et al. Differences in the contribution of the CTLA4 gene to susceptibility to fulminant and type 1A diabetes in Japanese patients. Diabetes Care 2008, 31:1608-1610.
44. Kikuoka N., et al. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies. Clin. Endocrinol. (Oxf.) 2001, 55:597-603.
45. Klitz W., et al. Association of CTLA-4 variation with type I diabetes in Filipinos. Immunogenetics 2002, 54:310-313.
46. Knip M., Veijola R., Virtanen S.M., Hyoty H., Vaarala O., Akerblom H.K. Environmental triggers and determinants of type 1 diabetes. Diabetes 2005, 54(Suppl. 2):S125-S136.
47. Korolija M., et al. Association of PTPN22 C1858T and CTLA-4 A49G polymorphisms with type 1 diabetes in Croatians. Diabetes Res Clin Pract 2009, 86:e54-e57.
48. Kouki T., Gardine C.A., Yanagawa T., Degroot L.J. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease. J. Endocrinol. Invest. 2002, 25:208-213.
49. Krokowski M., Bodalski J., Bratek A., Machejko P., Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. Diabetes Metab. 1998, 24:241-243.
50. Larsen Z.M., et al. IDDM12 (CTLA4) on 2q33 and IDDM13 on 2q34 in genetic susceptibility to type 1 diabetes (insulin-dependent). Autoimmunity 1999, 31:35-42.
51. Lee Y.J., et al. Association of CTLA4 gene A-G polymorphism with type 1 diabetes in Chinese children. Clin. Endocrinol. (Oxf.) 2000, 52:153-157.
52. Lee Y.J., et al. The promoter region of the CTLA4 Gene is associated with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 2001, 14:383-388.
53. Lemos M.C., et al. The CTLA4 +49 A/G polymorphism is not associated with susceptibility to type 1 diabetes mellitus in the Portuguese population. Int. J. Immunogenet. 2009, 36:193-195.
54. Liang H., Yagi K., Asano A., Kobayashi J., Mabuchi H. Association between CTLA-4 +49 A/G polymorphism and type 1B diabetes in Japanese population. Endocrine 2004, 25:105-109.
55. Ma Y., Tang X., Chang W., Gao L., Li M., Yan W. CTLA-4 gene A/G polymorphism associated with diabetes mellitus in Han Chinese. Chin. Med. J. (Engl.) 2002, 115:1248-1250.
56. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
57. McCormack R.M., Maxwell A.P., Carson D., Patterson C.C., Bingham A., Savage D.A. Possible association between CTLA4 DNA polymorphisms and early onset type 1 diabetes in a UK population. Genes Immun. 2001, 2:233-235.
58. Mochizuki M., et al. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 2003, 26:843-847.
59. Mojtahedi Z., Omrani G.R., Doroudchi M., Ghaderi A. CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diabetes Res Clin Pract 2005, 68:111-116.
60. Momin S., Flores S., Angel B.B., Codner D.E., Carrasco P.E., Perez-Bravo F. Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes. Diabetes Res Clin Pract 2009, 83:289-294.
61. Mosaad Y.M., Elsharkawy A.A., El-Deek B.S. Association of CTLA-4 (+49A/G) gene polymorphism with type 1 diabetes mellitus in Egyptian children. Immunol. Invest. 2012, 41:28-37.
62. Nistico L., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 1996, 5:1075-1080.
63. Ongagna J.C., Sapin R., Pinget M., Belcourt A. Markers for risk of type 1 diabetes in relatives of Alsacian patients with type 1 diabetes. Int. J. Exp. Diabetes Res. 2002, 3:1-9.
64. Osei-Hyiaman D., et al. Association of a novel point mutation (C159G) of the CTLA4 gene with type 1 diabetes in West Africans but not in Chinese. Diabetes 2001, 50:2169-2171.
65. Perez B.F., Codner D.E., Angel B.B., Balic N.I., Carrasco P.E. +49 A/G genetic polymorphism of cytotoxic T lymphocyte associated antigen 4 (CTLA-4) in type 7 diabetes: association with autoantibodies and cytokines. Rev. Med. Chil. 2009, 137:321-328.
66. Philip B., Isabel W. Association of cytotoxic T lymphocyte-associated antigen 4 gene single nucleotide polymorphism with type 1 diabetes mellitus in Madurai population of Southern India. Ind. J. Hum. Genet. 2011, 17:85-89.
67. Saleh H.M., Rohowsky N., Leski M. The CTLA4 -819 C/T and +49 A/G dimorphisms are associated with type 1 diabetes in Egyptian children. Ind. J. Hum. Genet. 2008, 14:92-98.
68. Takara M., et al. Association of CTLA-4 gene A/G polymorphism in Japanese type 1 diabetic patients with younger age of onset and autoimmune thyroid disease. Diabetes Care 2000, 23:975-978.
69. Todd J.A. A protective role of the environment in the development of type 1 diabetes?. Diabet. Med. 1991, 8:906-910.
70. Vaidya B., et al. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology (Oxford) 2002, 41:180-183.
71. Van der Auwera B.J., et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry. Clin. Exp. Immunol. 1997, 110:98-103.
72. Wang L., Yu H.W., Yan S.L., Zhao S.H., Wang Y.G., Wang F. The association of cytotoxic T lymphocyte-associated antigen 4 gene polymorphism with type 1 diabetes mellitus and autoimmune thyroid diseases in Chinese Han population. Chin. J. Endocrinol. Metab. 2001, 17:228-231.
73. Wang W.Y., Barratt B.J., Clayton D.G., Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat. Rev. Genet. 2005, 6:109-118.
74. Waterhouse P., et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995, 270:985-988.
75. Wells A.D., Walsh M.C., Bluestone J.A., Turka L.A. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J. Clin. Invest. 2001, 108:895-903.
76. Witas H.W., Jedrychowska-Danska K., Zawicki P. Changes in frequency of IDDM-associated HLA DQB, CTLA4 and INS alleles. Int. J. Immunogenet. 2010, 37:155-158.
77. Wood J.P., Pani M.A., Bieda K., Meyer G., Usadel K.H., Badenhoop K. A recently described polymorphism in the CD28 gene on chromosome 2q33 is not associated with susceptibility to type 1 diabetes. Eur. J. Immunogenet. 2002, 29:347-349.
78. Xiang B., Zhou Z.G., Yang L., Huang G., Lin J. Association between CTLA-4 gene A/G polymorphism and idiopathic type 1 diabetes. J. Clin. Res. 2006, 23:1521-1523.
79. Yanagawa T., et al. Lack of association between CTLA-4 gene polymorphism and IDDM in Japanese subjects. Autoimmunity 1999, 29:53-56.
80. Yang J.J., Zhang Y.H., Huo Z.H., Zhu X.Q., L.S., Yang Z. An analysis on susceptible genes polymorphism of Insulin dependent diabetes mellitus in children in Ningxia. J. Ningxia Med. Coll. 2006, 28:374-378.
81. Zalloua P.A., et al. Patients with early onset of type 1 diabetes have significantly higher GG genotype at position 49 of the CTLA4 gene. Hum. Immunol. 2004, 65:719-724.
82. Zhang S.W., Ding L., Li P.F., Qian C., Lan J.C., Zhao W.Z. Study on the cytotoxic T-lymphocyte related antigen 4 exons 1A/G49 polymorphism in patients of insulin-dependent diabetes mellitus and their parents. Zhonghua Yi Xue Za Zhi 2005, 85:788-789.